MoneyWorks4Me

Norris Medicines informs about outcome of board meeting

14 Feb 2025 Evaluate
Norris Medicines has informed that the Board of Directors at their Meeting held today, Thursday, 13th February, 2025 considered and approved the Un-audited Financial Results along with Limited Review Report for the quarter and nine months ended 31st December, 2024. A copy of the Un-audited Financial Results along with the Limited Review Report of the Auditors thereon issued in this regard is attached as Annexure I .

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1738.95
Dr. Reddys Labs. 1240.85
Cipla 1320.10
Lupin 1945.85
Zydus Lifesciences 1115.15
View more..